Thomas H. Brandt, III

Janssen Research and Development

Poster(s):

• Th164 - Suppression of Type 2 Inflammatory Responses by Half-life Extended IL-27 in Ovalbumin Induced Delayed Type Hypersensitivity
  Thursday, June 22, 2023

  7:30 AM – 7:30 PM